FORMULATIONS OF ABALOPARATIDE, TRANSDERMAL PATCHES THEREOF, AND USES THEREOF
Disclosed are abaloparatide formulations for transdermal delivery of a therapeutically effective amount of abaloparatide , as well as transdermal patches prepared using these formulations, methods of preparing the disclosed formulations and patches, and methods of using these formulations and patches to treat osteoporosis, osteopenia, osteoarthritis, and/or bone fracture, improve bone mineral density (BMD), improve trabecular bone score (TBS), and treat, prevent, and/or reduce bone fractures..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Europäisches Patentamt - (2022) vom: 18. Mai Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
HATTERSLEY GARY [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2022-05-18, Last update posted on www.tib.eu: 2023-09-27, Last updated: 2023-09-29 |
|---|
| Patentnummer: |
EP3998061 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA002354306 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA002354306 | ||
| 003 | DE-627 | ||
| 005 | 20240327215605.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240327s2022 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA002354306 | ||
| 035 | |a (EPA)EP3998061 | ||
| 035 | |a (EPA)60116311 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a HATTERSLEY GARY |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a FORMULATIONS OF ABALOPARATIDE, TRANSDERMAL PATCHES THEREOF, AND USES THEREOF |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2022-05-18, Last update posted on www.tib.eu: 2023-09-27, Last updated: 2023-09-29 | ||
| 520 | |a Disclosed are abaloparatide formulations for transdermal delivery of a therapeutically effective amount of abaloparatide , as well as transdermal patches prepared using these formulations, methods of preparing the disclosed formulations and patches, and methods of using these formulations and patches to treat osteoporosis, osteopenia, osteoarthritis, and/or bone fracture, improve bone mineral density (BMD), improve trabecular bone score (TBS), and treat, prevent, and/or reduce bone fractures. | ||
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a HARRIS ALAN |4 aut | |
| 700 | 0 | |a SAEH JAMAL |4 aut | |
| 700 | 0 | |a HAMED EHAB |4 aut | |
| 700 | 0 | |a BROWN KENNETH |4 aut | |
| 700 | 0 | |a DOHMEIER DANIEL |4 aut | |
| 700 | 0 | |a MOSEMAN JOAN |4 aut | |
| 700 | 0 | |a ZHANG YING |4 aut | |
| 700 | 0 | |a DICK LISA |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2022) vom: 18. Mai |
| 773 | 1 | 8 | |g year:2022 |g day:18 |g month:05 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/60116311/publication/EP3998061A1?q=EP3998061 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 18 |c 05 | ||